Brief: Genprex Entered Into First Amendment To Exclusive License Agreement With University Of Pittsburgh
Aug 22 (Reuters) - Genprex Inc GNPX.O :
* GENPREX INC - ON AUGUST 17, CO ENTERED INTO FIRST
AMENDMENT TO
EXCLUSIVE LICENSE AGREEMENT WITH UNIVERSITY OF PITTSBURGH
* GENPREX - AMENDMENT EXTENDS DATE BY WHICH CO IS REQUIRED
TO FILE
AN INVESTIGATIONAL NDA WITH U.S. FDA OR FOREIGN EQUIVALENT FOR
LICENSED TECHNOLOGY
Source text for Eikon: [https://bit.ly/3wkoaey]
Further company coverage: GNPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genprex
See all newsBrief: Genprex Announces Collaboration With Roche Diagnostics For Biomarker Assay Validation Studies
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Genprex Announces Ip Australia's Intent To Grant Patent For Reqorsa® Gene Therapy